原发性/转移性肝癌患者经肝动脉化疗栓塞术或消融术后发生肝脓肿的病原菌分布及耐药性分析

蔡妙甜; 梁连春

doi:10.3969/j.issn.1001-5256.2020.01.026

原发性/转移性肝癌患者经肝动脉化疗栓塞术或消融术后发生肝脓肿的病原菌分布及耐药性分析

DOI: 10.3969/j.issn.1001-5256.2020.01.026

首都医科大学附属北京佑安医院感染综合科

详细信息

中图分类号: R735.7;R575.4
计量
- 文章访问数: 1100
- HTML全文浏览量: 22
- PDF下载量: 221
- 被引次数: 0
出版历程
- 收稿日期: 2019-07-24
- 出版日期: 2020-01-20

Pathogen distribution and drug resistance in liver cancer patients with liver abscess after transarterial chemoembolization or ablation

Integrated Department of Infectious Diseases,Beijing YouAn Hospital,Capital Medical University

摘要

摘要: 目的探讨经肝动脉化疗栓塞术（TACE）或消融术治疗原发性或转移性肝癌后发生肝脓肿的病原菌分布特点及耐药情况,为临床合理使用抗菌药物提供依据。方法回顾性分析2011年1月-2018年12月北京佑安医院收治的经TACE/消融治疗后发生肝脓肿的原发性肝癌或转移性肝癌患者的肝脓液、血液培养分离菌株及药敏试验结果。计数资料组间比较采用χ2检验。结果共纳入49例患者,其中TACE组15例,消融组34例。TACE组共检出35株病原菌（肝脓液25株,血液10株）,革兰阴性菌、革兰阳性菌及真菌分别占54. 3%、40%及5. 7%;肝脓液培养分离病原菌（n=25）主要为肺炎克雷伯菌（n=5）、屎肠球菌（n=5）,铜绿假单胞菌（n=3）等;血培养分离病原菌（n=10）主要为屎肠球菌（n=4）、大肠埃希菌（n=1）、枸橼酸杆菌（n=1）等。消融组共检出64株病原菌（肝脓液43株,血液21株）,革兰阴性菌、革兰阳性菌及真菌分别占59. 4%、39. 1%及1. 6%;肝脓液培养分离病原菌（n=43）主要为大肠埃希菌（n=10）、肺炎克雷伯菌（n=9）、屎肠球菌（n=4）等;血培养分离病原菌（n=21）主要为肺...
- 肝肿瘤 /
- 肝脓肿 /
- 化学栓塞,治疗性 /
- 消融技术 /
- 病原菌
Abstract: Objective To investigate the pathogen distribution characteristics and drug resistance in patients with liver abscess after transarterial chemoembolization(TACE) or ablation for liver cancer,and to provide a basis for rational use of antibacterial agents in clinical practice. Methods A retrospective analysis was performed for the results of the strains isolated from liver pus and blood culture and drug sensitivity test of the liver cancer patients who were admitted to Beijing YouAn Hospital from January 2011 to December 2018 and developed liver abscess after TACE/ablation. The Chi-square test was used for comparison of categorical data between groups. Results A total of 49 patients were enrolled,with 15 in TACE group and 34 in ablation group. A total of 35 strains of pathogenic organisms were detected in the TACE group,and Gram-negative bacteria,Gram-positive bacteria,and fungi accounted for 54. 3%,40%,and 5. 7%,respectively; Klebsiella pneumoniae,Enterococcus faecium,and Pseudomonas aeruginosa were the main pathogenic bacteria isolated from liver pus culture,and Enterococcus faecalis,Escherichia coli,and Citrobacter were the main pathogenic bacteria isolated from blood culture. A total of 64 strains of pathogenic organisms were detected in the ablation group,and Gram-negative bacteria,Gram-positive bacteria,and fungi accounted for 59. 4%,39. 1%,and 1. 6%,respectively; Escherichia coli,Klebsiella pneumonia,and Enterococcus faecalis were the main pathogenic bacteria isolated from liver pus culture,and Klebsiella pneumoniae,Escherichia coli,and Enterococcus faecalis were the main pathogenic bacteria isolated from blood culture. Drug susceptibility results showed that in the strains of Klebsiella pneumoniae and Escherichia coli,the ESBL-producing strains accounted for 26. 3%(5/19) and 43. 8%(7/16),respectively,and the carbapenem-resistantstrains accounted for 10. 5%(2/19) and 12. 5%(2/16),respectively. Klebsiella pneumoniae had a drug resistance rate of ≤10. 5% to third-generation cephalosporins,quinolones,aminoglycosides,piperacillin/tazobactam,and carbapenems,and Escherichia coli had a drug resistance rate of 43. 8%-62. 5% to the tested cephalosporins,quinolones,and penicillins,18. 8% to piperacillin/tazobactam,and 12. 5%to carbapenems. In the strains of Enterococcus faecium and Enterococcus faecalis,the vancomycin-resistant strains accounted for 13. 3%(2/15) and 0,respectively,and the linezolid-resistant strains accounted for 13. 3%(2/15) and 28. 6%(2/7),respectively,while no teicoplanin-resistant strains were detected. Conclusion Klebsiella pneumoniae,Escherichia coli,Enterococcus faecium,and Enterococcus faecalis are the main pathogenic bacteria of liver abscess after TACE/ablation for liver cancer,and drugs should be selected based on drug susceptibility results to reduce drug-resistant strains.
- liver neoplasms /
- liver abscess /
- chemoembolization,therapeutic /
- ablation techniques /
- pathogen

HTML全文

参考文献(20)

[1] ONG GY,CHANGCHIEN CS,LEE CM,et al. Liver abscess complicating transcatheter arterial embolization:A rare but serious complication. A retrospective study after 3878 procedures[J]. Eur J Gastroenterol Hepatol,2004,16(8):737-742.

[2] ELIAS D,di PIETROANTONIO D,GACHOT B,et al. Liver abscess after radiofrequency ablation of tumors in patients with a biliary tract procedure[J]. Gastroenterol Clin Biol,2006,30(6-7):823-827.

[3] MEZHIR JJ,FONG Y,FLEISCHER D,et al. Pyogenic abscess after hepatic artery embolization:A rare but potentially lethal complication[J]. J Vasc Interv Radiol,2011,22(2):177-182.

[4] CHEN C,CHEN PJ,YANG PM,et al. Clinical and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma[J]. Am J Gastroenterol,1997,92(12):2257-2259.

[5] SHIN JU,KIM KM,SHIN SW,et al. A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma[J]. Dig Liver Dis,2014,46(9):813-817.

[6] KIM MH,CHOI MS,CHOI YS,et al. Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma[J]. Korean J Hepatol,2006,12(1):55-64.

[7] LV WF,LU D,HE YS,et al. Liver abscess formation following transarterial chemoembolization:Clinical features,risk factors,bacteria spectrum,and percutaneous catheter drainage[J].Medicine(Baltimore),2016,95(17):e3503.

[8] SHIBATA T,YAMAMOTO Y,YAMAMOTO N,et al. Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors:Incidence and risk factors[J]. J Vasc Interv Radiol,2003,14(12):1535-1542.

[9] WANG YM,WANG N,XU Y,et al. Severe complications after microwave ablation in 7403 cases with liver cancer[J]. Chin J Hepatobiliary Surg,2016,22(10):655-660.(in Chinese)王延明，王能，许赟，等．微波消融治疗7403例肝癌的严重并发症[J]．中华肝胆外科杂志，2016,22(10):655-660.

[10] SUN W,XU F,LI X,et al. A case series of liver abscess formation after transcatheter arterial chemoembolization for hepatic tumors[J]. Chin Med J(Engl),2017,130(11):1314-1319.

[11] CHOI D,LIM HK,KIM MJ,et al. Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas:Frequency and risk factors[J]. AJR Am J Roentgenol,2005,184(6):1860-1867.

[12] ZHOU YQ,ZENG M,ZHOU J,et al. Drug resistance of Enterobacteriaceae bacteria causing liver abscess[J]. J Clin Hepatol,2018,34(8):1750-1753.(in Chinese)周宜庆，曾敏，周洁，等．导致肝脓肿的肠杆菌科细菌的耐药性分析[J]．临床肝胆病杂志，2018,34(8):1750-1753.

[13] HU FP,GUO Y,ZHU DM,et al. Antimicrobial resistance profile of clinical isolates in hospitals across China:Report from the CHINET Surveillance Program,2017[J]. Chin J Infect Chemother,2018,18(3):241-251.(in Chinese)胡付品，郭燕，朱德妹，等．2017年CHINET中国细菌耐药性监测[J]．中国感染与化疗杂志，2018,18(3):241-251.

[14] ZHAO XJ,DENG LH,SHI DS,et al. Analysis of resistance mechanism of carbapenem-resistant Klebsiella pneumoniae[J]. Chin J Nosocomiol,2015,25(17):3851-3853,3883.(in Chinese)赵晓杰，邓丽华，施德仕，等．耐碳青霉烯类肺炎克雷伯菌耐药机制研究[J]．中华医院感染学杂志，2015,25(17):3851-3853,3883.

[15] LIU CL,XU HY,ZHANG ZP,et al. Analysis of antimicrobial resistance in Enterococcus isolates from 2009 to 2013[J].Chin J Infect Chemother,2015,15(2):142-145.(in Chinese)刘春林，徐红云，张志鹏，等．2009-2013年肠球菌属临床感染及耐药性分析[J]．中国感染与化疗杂志，2015,15(2):142-145.

[16] WANG S,HAO YH,YANG W,et al. Incidence and risk factors of liver abscess after radiofrequency ablation for liver cancer[J]. Chin J Interv Imaging Ther,2018,15(1):37-41.(in Chinese)王凇，郝艳红，杨薇，等．肝癌射频消融后肝脓肿的发生率及危险因素分析[J]．中国介入影像与治疗学，2018,15(1):37-41.

[17] WU YM,ZHOU RM,LIANG HM,et al. Clinical characteristics and predisposing factors for liver abscess formation after chemoembolization of hepatic malignancy[J/CD]. Chin J Clinicians(Electronic Edition),2011,5(2):343-346.(in Chinese)吴育民，周汝明，梁惠民，等．肝癌化疗栓塞并发肝脓肿的临床特点及易感因素分析[J/CD]．中华临床医师杂志(电子版)，2011,5(2):343-346.

[18] GESCHWIND JF,KAUSHIK S,RAMSEY DE,et al. Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors[J]. J Vasc Interv Radiol,2002,13(11):1163-1166.

[19] CHUANG JH,LEE SY,CHEN WJ,et al. Changes in bacterial concentration in the liver correlate with that in the hepaticojejunostomy after bile duct reconstruction:Implication in the pathogenesis of postoperative cholangitis[J]. World J Surg,2001,25(12):1512-1518.

[20] JIA Z,TU J,CAO C,et al. Liver abscess following transarterial chemoembolization for the treatment of hepatocellular carcinoma:A retrospective analysis of 23 cases[J]. J Cancer Res Ther,2018,14(Supplement):s628-s633.

施引文献

资源附件(0)

访问统计